Translate to...

SGLT-2 inhibitors may raise risk for diabetic ketoacidosis

SGLT-2 inhibitors may raise risk for diabetic ketoacidosis

(HealthDay)—In patients with type 2 diabetes, sodium-glucose cotransporter-2 (SGLT-2) inhibitors are associated with an increased risk for diabetic ketoacidosis (DKA), according to a study published online July 28 in the Annals of Internal Medicine.